Corneal neovascularization
MONDO:0006713New blood vessels originating from the corneal veins and extending from the limbus into the adjacent corneal stroma. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as trachoma, viral interstitial keratitis, microbial keratoconjunctivitis, and the immune response elicited by corneal transplantation.
12 clinical trials for this condition and its sub-types, 5 tagged with Corneal neovascularization itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Corneal neovascularization
-
Deep corneal vascularisation 0 trials
-
Could a light treatment for donor eyes save more sight?
Disease control Recruiting nowThis study tests whether treating donor corneal tissue with a special light-based process (cross-linking) before transplant can make it last longer and reduce rejection in people at high risk of graft failure. About 96 adults who need a high-risk cornea transplant will receive ei…
Phase 2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Light and vitamin B2 eyedrops tested against corneal blood vessel growth
Disease control Recruiting nowResearchers compare two versions of corneal crosslinking to treat corneal neovascularization, a condition where abnormal blood vessels grow into the clear front surface of the eye. Both versions use riboflavin eye drops followed by ultraviolet A light, but one shines the light fo…
Phase 2/3 • Sponsor: Price Vision Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy aims to clear cloudy corneas by zapping and blocking blood vessels
Disease control Recruiting nowThis study tests a two-step treatment for corneal neovascularization, where abnormal blood vessels grow on the clear front part of the eye. First, doctors use a fine needle with heat to seal off the vessels, then inject a drug called bevacizumab to prevent regrowth. The trial wil…
Sponsor: HoChiMinh City Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Eye injection could stop damaging blood vessels in Herpes-Related blindness
Disease control Recruiting nowThis study tests whether injecting anti-VEGF medication directly into the cornea can safely reduce abnormal blood vessel growth caused by herpes simplex keratitis. One hundred adults will receive either the injection plus antiviral eye drops or standard antiviral drops alone. Res…
Phase 1/2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Scientists hunt for biomarkers to unlock rare eye disease treatments
Knowledge-focused Recruiting nowThis study aims to find biological markers (biomarkers) in blood, tears, and eye cells from 110 adults with seven rare eye diseases. Researchers will compare these markers between patients and healthy controls to see if they differ and if they relate to disease symptoms. The goal…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC